SOD1 and amyotrophic lateral sclerosis: The ASO “Tofersen” (BIIB067) is under investigation for ALS treatment and has been designed to mediate RNase-H-dependent degradation of SOD1 mRNA to reduce the synthesis of SOD1 protein.